spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Flagship Ventures 

 HSMN NewsFeed - 26 May 2016
TransMedics, Inc. Announces Closing of $51.2 Million Growth Financing to Transform Organ Transplant Therapy
Devices Venture Capital
 HSMN NewsFeed - 26 Jan 2016
Codiak BioSciences Closes $61 Million Series B Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 15 Dec 2015
Dr. Elizabeth Nabel Joins Moderna Therapeutics’ Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Dec 2015
Flagship Ventures Launches Rubius To Develop Red-Cell Therapeutics(TM)
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Dec 2015
Syros Pharmaceuticals Appoints David A. Roth, M.D., as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 17 Nov 2015
ARCH Venture Partners, Flagship Ventures and MD Anderson Collaborate to Launch Codiak BioSciences
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 4 Nov 2015
Flagship Ventures Launches Evelo Therapeutics To Develop Microbiome Therapies for Cancer
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 8 Sep 2015
Selecta Announces $38 Million Series E Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 10 Aug 2015
Editas Medicine Raises $120 Million to Advance Genome Editing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 28 May 2015
Pronutria Biosciences Raises $39 Million in Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 14 May 2015
Denali Therapeutics Launches with Initial Investment to Discover and Develop Treatments for Neurodegenerative Diseases
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 7 Jan 2015
Blend Therapeutics Secures $21 Million Financing and Unveils Novel Pentarin(TM) Platform for Cancer Therapeutics
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 27 Oct 2014
Syros Pharmaceuticals Closes $53 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 15 Oct 2014
Selecta Announces More than $20 Million in Equity Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 13 Aug 2014
Seventh Sense Biosystems Closes $16 Million Series B Financing
Devices Diagnostics Venture Capital
 HSMN NewsFeed - 24 Jun 2014
Editas Medicine Appoints Katrine S. Bosley to Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Dec 2013
Visterra Closes $8.1 Million Financing and Expands Executive Team to Accelerate Company Growth
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 21 Nov 2013
Syros Pharmaceuticals Appoints Stéphane Bancel to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Nov 2013
Moderna Therapeutics Announces New Equity Financing, Raising $110M to Develop messenger RNA Therapeutics(TM)
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 15 Jul 2013
Visterra Appoints Brian Pereira, M.D., as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Jun 2013
Eleven Biotherapeutics Appoints Industry Veteran Karen L. Tubridy as Chief Development Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 May 2013
Syros Pharmaceuticals Appoints Eric R. Olson, Ph.D. as Chief Scientific Officer
Biopharmaceuticals Personalized Medicine Personnel
 HSMN NewsFeed - 30 Apr 2013
Henri A. Termeer Joins Moderna Therapeutics Board Of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Apr 2013
BIND Therapeutics Appoints Gregory I. Berk, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Mar 2013
Acceleron Receives Two FDA Orphan Designations for ACE-536
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 5 Mar 2013
Avedro Completes $43 Million Series D Financing
Devices Ophthalmology Venture Capital
 HSMN NewsFeed - 18 Dec 2012
Blend Therapeutics Closes $16 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Dec 2012
Blend Therapeutics Appoints Mark Iwicki as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Nov 2012
TransMedics, Inc. Secures $36 Million Round of Financing Led by Abrams Capital Management
Devices Venture Capital
 HSMN NewsFeed - 9 Nov 2012
Visterra Secures Financing From Gates Foundation and Omega to Close $26M Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 13 Jun 2012
Seventh Sense Biosystems Appoints President and CEO and Closes $10 Million Series-A Financing
Devices Venture Capital Personnel
 HSMN NewsFeed - 23 Dec 2011
Acceleron Secures $30M Private Financing
Biopharmaceuticals Mergers & Acquisitions Personnel
 HSMN NewsFeed - 17 Nov 2011
Agios Secures $78 Million in Oversubscribed Series C Financing
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 3 Nov 2011
Tangent Medical Closes $4.5 Million Series A Financing
Devices Venture Capital Personnel
 HSMN NewsFeed - 27 Sep 2011
Theracrine Appoints Steven Kelly as President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Sep 2011
Eleven Biotherapeutics Appoints Abbie Celniker, Ph.D., Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Jul 2011
TARIS Appoints Christopher Searcy as the Company’s Chief Business Officer
Biopharmaceuticals Urology Personnel
 HSMN NewsFeed - 7 Jul 2011
Avedro Completes $25 Million Series C Financing
Devices Ophthalmology Venture Capital
 HSMN NewsFeed - 30 Jun 2011
Sheila Gujrathi, M.D. Named Chief Medical Officer of Receptos
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 May 2011
Seventh Sense Biosystems Secures $4.5 Million of Two-Tranche $10 Million Extension of its Series A Financing
Devices Diagnostics Venture Capital
 HSMN NewsFeed - 13 Apr 2011
TARIS Closes $18.3 Million Series B Financing
Biopharmaceuticals Drug Delivery Venture Capital
 HSMN NewsFeed - 12 Apr 2011
AVEO Pharmaceuticals Appoints Henri A. Termeer to its Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 8 Feb 2011
Pervasis Receives FDA Fast Track Status for Vascugel(R) to Prevent Arteriovenous Access Failure in Patients Undergoing Hemodialysis
Biopharmaceuticals Interventional FDA
 HSMN NewsFeed - 2 Dec 2010
Faheem Hasnain Named President and Chief Executive Officer of Receptos
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Sep 2010
Third Rock Ventures Raises $426 Million Fund II
Venture Capital Personnel
 HSMN NewsFeed - 9 Sep 2010
Shire Expands Pipeline to Treat Orphan Muscle Diseases Through Collaboration With Acceleron Pharma
Biopharmaceuticals Licensing
 HSMN NewsFeed - 16 Aug 2010
Selecta Biosciences Appoints Werner Cautreels, Ph.D., as Company's First CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Jul 2010
TARIS Appoints Sarma Duddu as President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jun 2010
BIND Biosciences Secures $12.4 Million Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 29 Jun 2010
BIND Biosciences Appoints Ed Schnipper, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Jun 2010
Gilead Sciences to Acquire CGI Pharmaceuticals for up to $120 Million
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 1 Jun 2010
Tetraphase Closes $45 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 May 2010
Alvine Pharmaceuticals Announces Equity Investment by Abbott Biotech Ventures Inc.
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 5 Apr 2010
Selecta Closes $15 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 Feb 2010
Eleven Biotherapeutics Completes $35 Million Series A Funding to Advance Pipeline of Innovative Protein-Based Therapeutics
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 1 Feb 2010
Pervasis Therapeutics Receives FDA Clearance for Pivotal Phase 3 Trial of Vascugel(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 Jan 2010
BIND Biosciences, Inc. closes $11 M Series C financing round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 22 Dec 2009
Acceleron Pharma Expands Management Team with Two New Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Nov 2009
Receptos Completes $25M Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 4 Nov 2009
Acceleron Pharma Initiates First-in-Human Study of ACE-041, a Novel Angiogenesis Inhibitor, in Patients with Advanced Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Sep 2009
Pervasis Therapeutics Announces $17 Million in Financing and New Board Member
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 15 Sep 2009
Alvine Pharmaceuticals Raises $21.5 Million Series A Extension
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 5 May 2009
Pervasis Therapeutics Granted Orphan Drug Designation for Vascugel
Biopharmaceuticals Regenerative Medicine FDA
 HSMN NewsFeed - 25 Feb 2009
Selecta Biosciences, Inc. Closes $15.1M Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 Oct 2008
T2 Biosystems Raises $10.8 Million in Series B Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 6 Aug 2008
Tetraphase Pharmaceuticals Completes Series A Financing to Support the Advancement of Breakthrough Synthetic Chemistry Platform
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 Jul 2008
BG Medicine Closes $40 Million in Series D Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 7 Jul 2008
Agios Pharmaceuticals Closes $33 Million Series A Funding
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 30 Apr 2008
CoNCERT Pharmaceuticals Raises $37 Million in Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 22 Apr 2008
Resolvyx Pharmaceuticals Raises $25 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Apr 2008
VisEn Medical Raises $5.0 Million in Expanded Series B Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 9 Apr 2008
Tetraphase Pharmaceuticals Announces Appointment of Guy Macdonald as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Jan 2008
Pervasis Therapeutics Closes Additional $9.75 Million in Financing
Regenerative Medicine Venture Capital
 HSMN NewsFeed - 27 Nov 2007
BIND Biosciences, Inc. Closes $16M Series B Financing Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 Oct 2007
Acceleron Pharma Completes $31M Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 23 Oct 2007
VisEn Medical Raises $7 Million in Series B Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 24 Sep 2007
Bristol-Myers Squibb to Acquire Adnexus Therapeutics
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 24 Sep 2007
Acceleron Pharma Appoints Niels Borgstein, M.D. as Vice President, Medical Research
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Sep 2007
Acceleron Pharma Appoints John L. Knopf, Ph.D., as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Sep 2007
Ensemble Discovery Names Michael D. Taylor, PhD as President and Chief Executive Officer
Biopharmaceuticals Diagnostics Personnel
 HSMN NewsFeed - 11 Jul 2007
Adnexus Therapeutics Appoints Martin Freed, MD as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jul 2007
Alvine Pharmaceuticals Appoints Abhay Joshi, Ph.D. to President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Apr 2007
Acceleron Pharma Appoints James Desiderio, Ph.D. as Vice President, Program Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Apr 2007
TransMedics, Inc., Closes $25.5 Million in Series D Funding
Devices Venture Capital
 HSMN NewsFeed - 9 Apr 2007
PDL BioPharma Announces Election of L. Patrick Gage as Chairman of the Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Mar 2007
Acceleron Pharma Appoints Robert Steininger as Senior Vice President, Manufacturing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Mar 2007
Pervasis Therapeutics Launches Enrollment for Two Phase II Clinical Trials for Vascugel(TM)
Biopharmaceuticals Regenerative Medicine
 HSMN NewsFeed - 26 Feb 2007
Bristol-Myers Squibb Company and Adnexus Therapeutics Announce Collaboration to Develop and Commercialize Innovative Oncology Compounds
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 Nov 2006
Concert Pharmaceuticals Raises $48.5 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 28 Nov 2006
Adnexus Therapeutics Appoints Bruce A. Silver, MD, FACP as Medical Director
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 12 Oct 2006
Morphotek Raises $40 Million to Advance Its Antibody Pipeline
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 27 Sep 2006
Pervasis Therapeutics' Vascugel(TM) Initiates U.S. Clinical Trials Following Successful FDA IND Review
Regenerative Medicine FDA
 HSMN NewsFeed - 12 Sep 2006
Alvine Pharmaceuticals Closes a $21 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 21 Jun 2006
First AdNectin Therapeutic, CT-322, Clears FDA IND Review to Start Clinical Trials
Biopharmaceuticals Oncology
Return to NewsFeed  

 Additional items found! 16

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 16 additional stories matching:
Flagship Ventures
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.